Achim Rothe

Achim Rothe

UNVERIFIED PROFILE

Are you Achim Rothe?   Register this Author

Register author
Achim Rothe

Achim Rothe

Publications by authors named "Achim Rothe"

Are you Achim Rothe?   Register this Author

32Publications

654Reads

40Profile Views

Multi-specific antibodies for cancer immunotherapy.

BioDrugs 2014 Aug;28(4):331-43

Department I of Internal Medicine, Innate Immunity Group, University Hospital Cologne, Joseph Stelzmann Str. 9, 50937, Cologne, Germany,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s40259-014-0091-4
Publisher Site
http://dx.doi.org/10.1007/s40259-014-0091-4DOI Listing
August 2014

Anti-thymocyte globulins for post-transplant graft-versus-host disease prophylaxis-A systematic review and meta-analysis.

Crit Rev Oncol Hematol 2013 Oct 2;88(1):178-86. Epub 2013 Apr 2.

Department I of Internal Medicine, Stem Cell Transplantation Program, University Hospital of Cologne, Cologne, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2013.03.009DOI Listing
October 2013

Monoclonal antibody treatments for rheumatoid arthritis.

Expert Opin Biol Ther 2013 Sep 21;13(9):1257-72. Epub 2013 Jun 21.

University of Massachusetts Medical School, Division of Infectious Diseases and Immunology, Worcester, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2013.811230DOI Listing
September 2013

The properties of human CD40-activated B cells as antigen-presenting cells are not affected by PGE2.

Oncol Rep 2013 Mar 28;29(3):1061-5. Epub 2012 Dec 28.

Cologne Interventional Immunology (CII), Department I of Internal Medicine, University Hospital of Cologne, D-50924 Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2012.2215DOI Listing
March 2013

Recombinant proteins in rheumatology - recent advances.

N Biotechnol 2011 Sep 5;28(5):502-10. Epub 2011 Apr 5.

Department of Internal Medicine I, University Hospital Cologne, Joseph Stelzmann Street 9, 50931 Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nbt.2011.03.019DOI Listing
September 2011

Induction of in vitro and in vivo NK cell cytotoxicity using high-avidity immunoligands targeting prostate-specific membrane antigen in prostate carcinoma.

Mol Cancer Ther 2011 Jun 27;10(6):1036-45. Epub 2011 Apr 27.

Department I of Internal Medicine, University Hospital Cologne, LFI, Ebene 4, Room 703, Kerpener Str. 62, 50927 Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-10-1093DOI Listing
June 2011

Improvement of platelet dysfunction in chronic myelogenous leukemia following treatment with imatinib: a case report.

J Med Case Rep 2011 May 30;5:215. Epub 2011 May 30.

Department I of Internal Medicine, University Hospital Cologne, Kerpener Strasse 62, D-50924 Köln, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1752-1947-5-215DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117828PMC
May 2011

Therapeutic advances in rheumatology with the use of recombinant proteins.

Nat Clin Pract Rheumatol 2008 Nov 23;4(11):605-14. Epub 2008 Sep 23.

Department of Internal Medicine at the University Hospital of Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncprheum0909DOI Listing
November 2008

Ribosome display and selection of human anti-cD22 scFvs derived from an acute lymphocytic leukemia patient.

Biol Chem 2008 Apr;389(4):433-9

CSIRO Molecular and Health Technologies, 343 Royal Parade, Parkville, Victoria 3052, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/BC.2008.045DOI Listing
April 2008

Selection of human anti-CD28 scFvs from a T-NHL related scFv library using ribosome display.

J Biotechnol 2007 Jul 24;130(4):448-54. Epub 2007 May 24.

Department of Internal Medicine I, Laboratory of Immunotherapy, University Hospital Cologne, Joseph Stelzmann street 9, 50931 Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbiotec.2007.05.012DOI Listing
July 2007

Novel proteins in emulsions using in vitro compartmentalization.

Trends Biotechnol 2006 Dec 19;24(12):587-92. Epub 2006 Oct 19.

CSIRO Molecular and Health Technologies, 343 Royal Parade, Parkville, Victoria 3052, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tibtech.2006.10.007DOI Listing
December 2006

In vitro display technologies reveal novel biopharmaceutics.

FASEB J 2006 Aug;20(10):1599-610

CSIRO Molecular and Health Technologies, Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1096/fj.05-5650revDOI Listing
August 2006

Ribosome display for improved biotherapeutic molecules.

Expert Opin Biol Ther 2006 Feb;6(2):177-87

CSIRO Molecular and Health Technologies, 343 Royal Parade, Parkville, Victoria 3052, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.6.2.177 DOI Listing
February 2006

A new generation of protein display scaffolds for molecular recognition.

Protein Sci 2006 Jan;15(1):14-27

Preventative Health National Research Flagship, Parkville, Victoria 3052, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1110/ps.051817606
Publisher Site
http://dx.doi.org/10.1110/ps.051817606DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2242358PMC
January 2006

The fully human anti-CD30 antibody 5F11 activates NF-{kappa}B and sensitizes lymphoma cells to bortezomib-induced apoptosis.

Blood 2005 Sep 5;106(5):1839-42. Epub 2005 May 5.

University Hospital of Cologne, Department of Internal Medicine, Kerpener Str. 62 D-50924 Köln, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-01-0427DOI Listing
September 2005

Combination of the human anti-CD30 antibody 5F11 with cytostatic drugs enhances its antitumor activity against Hodgkin and anaplastic large cell lymphoma cell lines.

J Immunother 2004 Sep-Oct;27(5):347-53

Laboratory of Immunotherapy, Department I for Internal Medicine, University Hospital Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
February 2005